Results 1 to 10 of about 6,207 (120)

Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria

open access: yesFrontiers in Pharmacology, 2021
Objectives: Reimbursement decisions on new medicines require an assessment of their value. In Austria, when applying for reimbursement of new medicines, pharmaceutical companies are also obliged to submit forecasts of future sales.
Michael Kossmeier   +9 more
doaj   +1 more source

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement

open access: yesFrontiers in Pharmacology, 2023
Legislations incentivising orphan drug development and scientific advances have made orphan drugs pharma’s high-end favourite for the past two decades. Currently, around 50% of new marketing authorizations are for orphan drugs. For third-party healthcare
Hans-Georg Eichler   +3 more
doaj   +1 more source

A Digital Individual Benefit Statement to Mitigate the Risk of Poverty in Retirement: The Case of Switzerland

open access: yesRisks, 2021
Old-age retirement benefits are a major concern among the Swiss population but estimating one’s revenue after retirement is challenging due to the Swiss social system’s complexity.
Catherine Equey Balzli
doaj   +1 more source

Social insurance for clergymen under canon law

open access: yesSeminare, 2022
The present paper raises the issue of social insurance for the clergy in the Catholic Church. The first part provides the historical background, norms of the 1917 Code of Canon Law and indications of the Second Vatican Council.
Arkadiusz Domaszk
doaj   +1 more source

Mismatch Repair Protein Expression and Microsatellite Instability in Cutaneous Squamous Cell Carcinoma

open access: yesCurrent Oncology, 2021
There exist relatively sparse and conflicting data on high-level microsatellite instability (MSI-H) and deficient mismatch repair (dMMR) in cutaneous malignancies. We aimed to determine the expression profiles of MMR proteins (MSH2, MSH6, MLH1, and PMS2)
Thilo Gambichler   +11 more
doaj   +1 more source

Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years’ multi-stakeholder dialogue on improving access in Europe via MoCA

open access: yesOrphanet Journal of Rare Diseases, 2023
Background The Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA) was established in 2013 with the intention of developing a coordinated mechanism between volunteering EU stakeholders and developers of Orphan Medicinal Products (OMPs) to
Maria Cavaller-Bellaubi   +10 more
doaj   +1 more source

The impact of pension insurance types on the health of older adults in China: a study based on the 2018 CHARLS data

open access: yesFrontiers in Public Health, 2023
IntroductionPension insurance is an essential safeguard for the quality of life and health of older adults because it provides a stable and dependable source of income after retirement.
Dongliang Yang   +3 more
doaj   +1 more source

Satisfaction of staff of Swiss insurance companies with medical appraisals: a cross sectional study

open access: yesBMC Research Notes, 2011
Background A high quality of timely delivered medical appraisals is crucial for social and other insurances to judge possible occupational reintegration measures for patients with medical conditions who are in danger to lose their job. However, little is
Gyr Niklaus   +5 more
doaj   +1 more source

New Work Forms: How to Integrate Them in Our Social Insurances

open access: yesWirtschaftsdienst, 2020
The increase in the group of atypical workers means that their social security protection needs reviewing. How far should we go in approaching social security for self-employed workers, flex workers, crowd workers and all new employment relationships ...
Saskia Montebovi   +2 more
doaj   +1 more source

Commentary on CDC data showing an increased risk for pediatric diabetes with COVID‐19 infection

open access: yesJournal of Diabetes, 2022
Highlights We question certain aspects of the recent Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (January 2022) showing a significant increase in the incidence of diabetes in children after COVID‐19 infection ...
Jasmine Gujral   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy